Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PFIZER INC Director's Dealing 2008

Mar 4, 2008

29831_dirs_2008-03-03_d922e7b7-905b-4f9b-b3b2-68a5ad65da0d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2008-02-28

Reporting Person: FECZKO JOSEPH M (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2008-02-28 Common Stock A 16462 Acquired 362955.00 Direct
2008-02-28 Common Stock A 6100 Acquired 369055.00 Direct
2008-02-28 Common Stock F 2306 $22.55 Disposed 366749.00 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2008-02-28 Stock Appreciation Rights $22.55 A 66607 Acquired 2013-02-28 Common Stock (66607.00) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 6879.00 Indirect
Common Stock 10931.00 Indirect
Common Stock 2925.00 Indirect

Footnotes

F1: The reported transaction constitutes the grant of restricted stock units.

F2: The reported transaction constitutes the earn-out of Performance-Contingent Shares.

F3: I hereby disclaim beneficial ownership of all shares held by members of my family.

F4: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant